NDC 0781-3003-70
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3003
- Requested NDC
- 0781-3003-70
- Package NDCs from labels
- 0781-3003-70
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3003-70 | ML - Milliliter | 0781-3003 | c5bea606-8733-403f-9922-27e7cac36f13 | 1 | 2012-07-24 |
| 0781-3003-75 | ML - Milliliter | 0781-3003 | 05b8546b-a7c0-4026-a387-1c23686a3b14 | 1 | 2012-07-24 |
| 0781-3003-92 | ML - Milliliter | 0781-3003 | 733f9055-a903-4ed2-b48c-7d44cb248059 | 1 | 2012-07-24 |
| 0781-3003-95 | ML - Milliliter | 0781-3003 | a6c41535-8339-4e65-88d7-dcfa7adbfaed | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Sandoz Inc | 7ba9a729-a73a-4a13-a336-0284cc8a67e1 | 2024-02-28 | Warnings, Adverse reactions | Sandoz Inc |
| Amoxicillin | AMOXICILLIN | Sandoz Inc | 13bd4214-9b7f-425b-af5f-fc1ddc678230 | 2024-02-22 | Warnings, Adverse reactions | Sandoz Inc |
| Palonosetron Hydrochloride | PALONOSETRON HYDROCHLORIDE | Sandoz Inc | aff1505c-8d34-46e6-9559-c5b112887875 | 2024-02-05 | Warnings, Adverse reactions | Sandoz Inc |
| FLUVASTATIN SODIUM ER | FLUVASTATIN SODIUM | Sandoz Inc | 5ab4296c-87c2-4c64-b218-d620eef51310 | 2024-01-31 | Warnings, Adverse reactions | Sandoz Inc |
| FLUMAZENIL | FLUMAZENIL | HF Acquisition Co. LLC, DBA Health First | 744ef484-ef46-8d62-e053-2a91aa0a0c05 | 2024-01-29 | Warnings, Adverse reactions | FLUMAZENIL FLUMAZENIL |
| Cosyntropin | COSYNTROPIN | Sandoz Inc | 1342169c-e214-4f22-8363-1fd45b85d1e8 | 2024-01-10 | Warnings, Adverse reactions | Sandoz Inc |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | Sandoz Inc |
| MAXITROL | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc | 5776c435-ac60-49b6-8db1-23a3012b9155 | 2023-12-29 | Warnings, Adverse reactions | Sandoz Inc |
| Lescol XL | FLUVASTATIN SODIUM | Sandoz Inc | 726ea2db-f1b0-4b73-a515-02157db88a42 | 2023-12-13 | Warnings, Adverse reactions | Sandoz Inc |
| Entacapone | ENTACAPONE | Sandoz Inc | ad4b6d79-efd3-4c43-b4dc-5afdacf939a4 | 2023-11-30 | Warnings, Adverse reactions | Sandoz Inc |
| Anectine | SUCCINYLCHOLINE CHLORIDE | Sandoz Inc | a1e5d29f-111e-4a44-addf-beeb6ea81711 | 2023-11-29 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Anectine | SUCCINYLCHOLINE CHLORIDE | Sandoz Inc | 04a4e6f5-6fa1-42e1-a3f9-21fca7786b15 | 2023-11-29 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Azopt | BRINZOLAMIDE | Sandoz Inc | 0afb6589-51ba-432c-aed1-20a12d5d3455 | 2023-11-24 | Warnings, Adverse reactions | Sandoz Inc |
| Vivelle-Dot | ESTRADIOL | Sandoz Inc | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Betaxolol Hydrochloride | BETAXOLOL HYDROCHLORIDE | Sandoz Inc | a73519d5-546c-4377-92ed-0d4be2685d60 | 2023-10-31 | Warnings, Adverse reactions | Sandoz Inc |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE | Sandoz Inc | 6f637e8d-7c2e-47fa-a43c-3250c51aed77 | 2023-10-13 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Edaravone | EDARAVONE | Sandoz Inc | ae940bc6-1e6a-4b76-825c-bd2e1925e39a | 2023-10-01 | Warnings, Adverse reactions | Sandoz Inc |
| HYCAMTIN | TOPOTECAN | Sandoz Inc | b23b46f5-c276-47f5-8bbd-940680b3f579 | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Clarithromycin | CLARITHROMYCIN | Sandoz Inc | 22457862-0f88-4be8-b507-1c8f264269f2 | 2023-09-13 | Warnings, Adverse reactions | Sandoz Inc |
| Bimatoprost | BIMATOPROST | Sandoz Inc | 27bef7e1-750a-4ac1-ab5f-e4c0121ffcbc | 2023-08-31 | Warnings, Adverse reactions | Sandoz Inc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.